A Study on Relationship Between Resected Normal Liver Parenchymal Volume（RNLV）and Post-Hepatectomy Liver Failure (PHLF)
Recruiting now
Conditions studied: Liver Failure
In brief
The post-hepatotectomy liver failure (PHLF) is still the most worrisome complication of hepatic resection. Surgeons have always been making efforts to preoperatively predict PHLF using kinds of techniques, scoring systems, and variables. The investigators of this study tried to create an individual predictive model based on the variable, resected normal parenchymal volume (RNLV), then assessing the performance and value of the model in clinical practice.
Key facts
- Study ID
- NCT06366048
- Run by
- National Natural Science Foundation of China
- People needed
- 1600
- Starts
- 2022-12-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- selective hepatectomies;
- histologically confirmed as HCC and ICC
- complete and accessible data
You may not qualify if…
- any history of Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)
- any history of portal vein embolism (PVE)
- any history of tumor rupture
- emergency surgery
- pathologically diagnosed with neither HCC nor ICC
- concomitant resection of gastrointestinal organs, spleenectomy or other organs
Where it is running
- Mengchao Hepatobiliary Hospital of Fujian Medical University — Fujian, Shanghai Municipality, China (enrolling)
- The Third Affiliated Hospital of Naval Medical University — Shanhai, Shanghai Municipality, China (enrolling)
- Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, Mengchao Hepatobiliary Hospital of Fujian Medical University — Shenzhencun, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.